173 related articles for article (PubMed ID: 37003608)
1. Preliminary Clinical and Laser Speckle Contrast Analysis Data on Selexipag Efficacy for the Treatment of Digital Vasculopathy in Systemic Sclerosis.
Di Battista M; Della Rossa A; Da Rio M; De Mattia G; Morganti R; Mosca M
J Rheumatol; 2023 Aug; 50(8):1029-1031. PubMed ID: 37003608
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Data on Efficacy and Safety of Selexipag for Digital Systemic Sclerosis Vasculopathy.
Di Battista M; Della Rossa A; Mosca M
J Rheumatol; 2024 Jul; ():. PubMed ID: 38879188
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis?
Barsotti S; d'Ascanio A; Valentina V; Chiara S; Silvia B; Laura A; Mosca M; Della Rossa A
Clin Rheumatol; 2020 Jan; 39(1):69-75. PubMed ID: 31317425
[TBL] [Abstract][Full Text] [Related]
4. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review.
Pauling JD; Hackett N; Guida A; Merkel PA
Semin Arthritis Rheum; 2020 Oct; 50(5):1114-1130. PubMed ID: 32920325
[TBL] [Abstract][Full Text] [Related]
5. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.
Denton CP; Hachulla É; Riemekasten G; Schwarting A; Frenoux JM; Frey A; Le Brun FO; Herrick AL;
Arthritis Rheumatol; 2017 Dec; 69(12):2370-2379. PubMed ID: 29193819
[TBL] [Abstract][Full Text] [Related]
7. Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients.
Ruaro B; Sulli A; Smith V; Paolino S; Pizzorni C; Cutolo M
Microvasc Res; 2015 Sep; 101():82-5. PubMed ID: 26142117
[TBL] [Abstract][Full Text] [Related]
8. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
[TBL] [Abstract][Full Text] [Related]
9. The safety and persistence of intravenous iloprost in systemic sclerosis.
Martins P; Dourado E; Fonseca JE; Romão V; Resende C
ARP Rheumatol; 2022; 1(2):122-128. PubMed ID: 35810370
[TBL] [Abstract][Full Text] [Related]
10. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
Shah AA; Schiopu E; Chatterjee S; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V
J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
[TBL] [Abstract][Full Text] [Related]
11. A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis.
Shenavandeh S; Sepaskhah M; Dehghani S; Nazarinia M
Clin Rheumatol; 2022 Jan; 41(1):95-104. PubMed ID: 34471968
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
[TBL] [Abstract][Full Text] [Related]
13. Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis.
Ruaro B; Paolino S; Pizzorni C; Cutolo M; Sulli A
Reumatismo; 2017 Sep; 69(3):134-136. PubMed ID: 28933138
[TBL] [Abstract][Full Text] [Related]
14. Raynaud phenomenon and digital ulcers in systemic sclerosis.
Hughes M; Allanore Y; Chung L; Pauling JD; Denton CP; Matucci-Cerinic M
Nat Rev Rheumatol; 2020 Apr; 16(4):208-221. PubMed ID: 32099191
[TBL] [Abstract][Full Text] [Related]
15. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.
Ingegnoli F; Schioppo T; Allanore Y; Caporali R; Colaci M; Distler O; Furst DE; Hunzelmann N; Iannone F; Khanna D; Matucci-Cerinic M
Semin Arthritis Rheum; 2019 Feb; 48(4):686-693. PubMed ID: 29706243
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the pathogenesis and management of Raynaud's phenomenon and digital ulcers.
Herrick AL
Curr Opin Rheumatol; 2016 Nov; 28(6):577-85. PubMed ID: 27541182
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
Motegi SI; Sekiguchi A; Saito S; Ishibuchi H; Kishi C; Yasuda M; Ishikawa O
J Dermatol; 2018 Mar; 45(3):349-352. PubMed ID: 29164658
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series study
Xu B; Yu Y; Liang J; Xu G; Chen W; Lin J; Hu S
J Dermatolog Treat; 2023 Dec; 34(1):2276046. PubMed ID: 38073230
[No Abstract] [Full Text] [Related]
19. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
[TBL] [Abstract][Full Text] [Related]
20. The safety of iloprost in systemic sclerosis in a real-life experience.
Bellando-Randone S; Bruni C; Lepri G; Fiori G; Bartoli F; Conforti ML; Moggi-Pignone A; Guiducci S; Giuggioli D; Colaci M; Spinella A; Ferri C; Matucci-Cerinic M
Clin Rheumatol; 2018 May; 37(5):1249-1255. PubMed ID: 29470737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
